Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

Cellular proliferation and tumor suppression pathways as potential targets in clinically aggressive sarcomas.

Removing tumors by surgery can be painful, too, yet if they are not removed, they have a rare risk of developing into cancer called malignant peripheral nerve sheath tumor (MPNST), which is rare.

EMA committee recommends marketing approval for SpringWorks’ mirdametinib to treat adult & paediatric patients with NF1-PN: Stamford, Connecticut Tuesday, May 27, 2025, 12:00 Hr ...

Global inequities in sarcoma clinical trials: A comprehensive analysis over the last decade. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full ...

Multiple Sclerosis affects millions worldwide with diverse symptoms; early diagnosis, multidisciplinary care, and awareness ...

Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China ...

The jugulocarotid and vagal neurovascular bundle were dissected from the capsule of the mass, and the spinal nerve was preserved. The tumor was freed from the cervical vertebrae and pharynx. The ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

There may be a strategy that regulates inflammation responsible for causing nerve pain due to chemotherapy-induced side effects of treatment, according to research from Virginia Commonwealth ...